drugset / Trial / NCT02547350
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the efficacy of prophylactic intravesical chemotherapy (different chemotherapy drugs and dosage regimen) in the prevention of bladder recurrence after nephroureterectomy for upper tract urothelial carcinoma (UTUC).
Timeline
- Start
- 2015-09
- Primary completion
- 2020-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pharmorubicin | Unknown | 50 mg | Other |
| Subject | Pirarubicin | Small molecule | 30 mg | Other |